Advertisement


Lawrence H. Einhorn, MD, on CINV Clinical Trial Results: The Alliance A221301 Study

2015 Palliative Care in Oncology Symposium

Advertisement

Lawrence H. Einhorn, MD, of Indiana University Simon Cancer Center, discusses the encouraging study findings on olanzapine for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy (Abstract 176).



Related Videos

Palliative Care
Symptom Management

Eduardo Bruera, MD, on Cachexia Assessment and Management State of the Art

Eduardo Bruera, MD, of The University of Texas MD Anderson Cancer Center, discusses exciting developments in the assessment and management of cachexia, as well as a number of emerg...

Palliative Care

Anthony L. Back, MD, on Improving Communication Between Patient and Provider

Anthony L. Back, MD, of Seattle Cancer Care Alliance, summarizes a general session on best practices and novel tools for enhancing communication between patients and oncology provi...

Palliative Care

Eric Roeland, MD: Toward Better Treatment for Cachexia

Given the challenges of recruiting patients for palliative care studies, Eric Roeland, MD, of the University of California, San Diego, discusses a way to increase the participation...

Palliative Care

Betty Ferrell, PhD, RN, on Depression and Cancer Care

Betty Ferrell, PhD, RN, of City of Hope, discusses two papers that look at an important issue from different perspectives: depression and anxiety among family caregivers of patient...

Palliative Care
Symptom Management
Lung Cancer

Amelie Harle, MD, on Aprepitant for Cough in Lung Cancer

Amelie Harle, MD, of the Christie NHS Foundation Trust, discusses a clinical trial––the first of its kind—designed to assess the efficacy of an antitussive in patients with lung ca...

Advertisement

Advertisement



;
Advertisement